Can a sedative improve blood flow in septic shock? a pilot study investigates

NCT ID NCT07657715

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at how the sedative dexmedetomidine affects the smallest blood vessels in people with septic shock, a life-threatening condition caused by severe infection. Researchers will measure blood flow in the tongue's tiny vessels and other key blood pressure indicators before and after giving the drug. The goal is to understand if dexmedetomidine helps or harms circulation in these critically ill patients, providing clues for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
dexmedetomidine
What this could lead to
If successful, this could help doctors understand how to better manage blood flow in septic shock patients, potentially improving treatment strategies.
What could go wrong
This is a very small, early pilot study with only 20 participants, so results may not apply broadly. The drug may cause low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, 233000, China

  • The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

    Wuhu, Anhui, 241000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.